Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimising Isolation, Quarantine and Distancing Study for COVID-19

NCT07337382 is registered in ClinicalTrials.gov with Macfarlane Burnet Institute for Medical Research and Public Health Ltd as lead sponsor.

NCT NCT07337382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07337382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimising Isolation, Quarantine and Distancing Study for COVID-19
Lead sponsor
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Phase
Observational
Overall status
Active, not recruiting
Start date
September 30, 2020
Completion date
June 30, 2026
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19